Arcede Pharma is a pharmaceutical company. The company conducts research and development in the area of chronic obstructive pulmonary disease, including abbreviated COPD, and severe asthma. The company's product portfolio includes a number of drugs intended for the treatment and alleviation of the above ailments. The largest operations are in the Nordic market. The company was established via a spin-off of Respiratorius in 2022 and is headquartered in Lund.

Quotes for Arcede Pharma AB

Right Now

+/-
0.61
%
23,55%
Latest
3.2
High
3.5
Low
2.6
Volume
275 544
Turnover (SEK)
857 307
Market Value (MSEK)
18,7
Time (Latest trade)
2023-02-03 17:24

Board

CEO

  • Mia Lundblad

Chairperson of the Board

  • Ingemar Kihlström

Board

  • Åsa Kornfeld
  • Johanna Asklin
  • Laurent Pacheco

Upcoming reports

  • 2023-02-13 Bokslutskommuniké 2023

  • 2023-05-12 Årsstämma 2023

Annual reports, prospectus etc.